臨床試験を検索:Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antaci
合計331423件
-
EpimmunePharmexa A/S; Pharmexa-Epimmuneわからない
-
Cell Genesys完了
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完了
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; United States Department... と他の協力者完了
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完了
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Beth Israel Deaconess Medical Center; Brigham...完了
-
Hadassah Medical OrganizationわからないFemale Patients Aged 5-35 Prior to Systemic Chemotherapy | With Significant Risk of Ovarian Toxicityイスラエル
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完了
-
Callisto Pharmaceuticals完了
-
Fred Hutchinson Cancer CenterNational Institutes of Health (NIH); Burroughs Wellcome完了
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完了
-
SanofiBristol-Myers Squibb完了
-
The Cleveland Clinic終了しました
-
Cierra一時停止
-
Vertex Pharmaceuticals Incorporated完了
-
Wyeth is now a wholly owned subsidiary of Pfizer完了
-
Wyeth is now a wholly owned subsidiary of Pfizer完了
-
Stanford UniversityMedtronic完了
-
University of PittsburghSanofi完了
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完了
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完了
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完了
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong; Princess Margaret...完了
-
University of ZurichAstraZeneca完了